Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
"There is a considerable risk that more young people will slip into long-term worklessness, unless government acts to address the causes of this rise."
。服务器推荐对此有专业解读
15:56, 27 февраля 2026Россия。业内人士推荐WPS下载最新地址作为进阶阅读
Раскрыты подробности похищения ребенка в Смоленске09:27